Risk Factors of Hepatocellular Carcinoma Recurrence After Liver Transplantation: Accuracy of the Alpha-Fetoprotein Model in a Single-Center Experience

2015 ◽  
Vol 47 (1) ◽  
pp. 84-89 ◽  
Author(s):  
M.A. Varona ◽  
A. Soriano ◽  
A. Aguirre-Jaime ◽  
S. Garrido ◽  
E. Oton ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Alpha Fetoprotein ◽  
Single Center ◽  
Single Center Experience ◽  
Hepatocellular Carcinoma Recurrence

Liver transplantation for hepatocellular carcinoma: A single center experience

2004 ◽  
Vol 42 (05) ◽  
Author(s):  
V Stadlbauer ◽  
S Schaffellner ◽  
D Kniepeiss ◽  
E Jakoby ◽  
F Iberer ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Single Center ◽  
Single Center Experience

Hepatocellular Carcinoma Occurrence/Recurrence after Direct-Acting Antivirals for Hepatitis C in Egyptian Cohort: Single-Center Experience

2019 ◽  
Vol 37 (6) ◽  
pp. 488-497
Author(s):  
Sameh A. Lashen ◽  
Mohammed M. Shamseya ◽  
Marwa A. Madkour
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C ◽  
De Novo ◽  
Independent Predictor ◽  
Alpha Fetoprotein ◽  
Direct Acting Antivirals ◽  
Single Center ◽  
Single Center Experience ◽  
Direct Acting ◽  
Hcc Recurrence

Background: Conflicting data have been published about the risk of hepatocellular carcinoma (HCC) following direct-acting antivirals (DAAs). We investigated the incidence of HCC occurrence/recurrence after DAAs therapy. Patients and Methods: Retrospectively, we analyzed data of 392 patients with F3–4 fibrosis and cirrhosis treated by DAAs during the period from August 2015 to May 2018. In HCC-experienced patients, HCC treatment modality, and the duration between HCC management and DAAs initiation were recorded. In all patients, pretreatment clinicolaboratory evaluation, and imaging before, during and after DAAs were done. Results: De novo HCC occurred in 7.6% of naïve patients, while recurrence appeared in 28% of patients with previous HCC. Pretreatment alpha-fetoprotein was an independent predictor of HCC occurrence, while the time between HCC ablation and the beginning of DAAs was the only predictor of HCC recurrence (p < 0.001). Half of the patients who started DAAs before 6 months had HCC recurrence, while patients who started DAAs at ≥6 months had no recurrence (p< 0.0001). Conclusions: Although HCC occurrence after DAAs was not high, recurrence was apparently high. Pretreatment alpha-fetoprotein is a predictor for de novo HCC. The time between HCC ablation and DAAs was the strongest predictor of recurrence.

Outcome of Liver Transplantation for Hepatocellular Carcinoma - a Single Center Experience

2012 ◽  
Vol 94 (10S) ◽  
pp. 632
Author(s):  
S. Iacob ◽  
R. Iacob ◽  
M. Grigorie ◽  
D. Hrehoret ◽  
V. Brasoveanu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Single Center ◽  
Single Center Experience

Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience in Taiwan

2008 ◽  
Vol 85 (3) ◽  
pp. 398-406 ◽  
Author(s):  
Allan Concejero ◽  
Chao-Long Chen ◽  
Chih-Chi Wang ◽  
Shih-Ho Wang ◽  
Chih-Che Lin ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Single Center ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Single Center Experience

Orthotopic Liver Transplantation for Hepatocellular Carcinoma: A Thirteen-Year Single-Center Experience

2008 ◽  
Vol 40 (9) ◽  
pp. 2975-2977 ◽  
Author(s):  
J.F. Castroagudín ◽  
E. Molina ◽  
M. Bustamante ◽  
S. Tomé ◽  
E. Otero ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Orthotopic Liver Transplantation ◽  
Single Center ◽  
Single Center Experience

scholarly journals Risk factors for hepatocellular carcinoma recurrence after liver transplantation

2020 ◽  
Vol 2020 ◽  
Author(s):  
Pierluigi Toniutto ◽  
Ezio Fornasiere ◽  
Elisa Fumolo ◽  
Davide Bitetto
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Hepatocellular Carcinoma Recurrence

scholarly journals In-hospital mortality of liver transplantation and risk factors: a single-center experience

2021 ◽  
Vol 9 (5) ◽  
pp. 369-369
Author(s):  
Xing-Mao Zhang ◽  
Hua Fan ◽  
Qiao Wu ◽  
Xin-Xue Zhang ◽  
Ren Lang ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
Hospital Mortality ◽  
Single Center ◽  
Single Center Experience
Sign in / Sign up

Export Citation Format

Share Document